Increase in gap junction conductance by an antiarrhythmic peptide

Area of Science:

• Cardiology
• Molecular Biology
• Pharmacology

Background:

• Impaired cellular coupling via gap junctions is a key factor in cardiac arrhythmia development.
• Existing antiarrhythmic drugs have significant adverse effects, highlighting the need for novel therapeutic agents.
• Previous research suggested AAP10 may improve cellular coupling, but direct evidence was lacking.

Purpose of the Study:

• To investigate the hypothesis that the novel antiarrhythmic peptide AAP10 enhances cellular coupling by acting on cardiac gap junctions.
• To directly measure the effect of AAP10 on gap junction conductance in cardiac myocytes.

Main Methods:

• Experiments were conducted on isolated rabbit papillary muscle and guinea-pig cardiac myocytes.
• Stimulus-response intervals were measured in papillary muscle after AAP10 application.
• Direct measurement of gap junction conductance was performed using double-cell voltage-clamp techniques.

Main Results:

• AAP10 (1 microM) decreased the stimulus-response interval in papillary muscle by approximately 10%.
• In guinea-pig myocytes, AAP10 (10 nM) reversed the decrease in gap junction conductance, causing it to increase (+1.0 +/- 0.7 nS/min).
• AAP10 did not affect transmembrane action potential parameters or the IV relationship of cardiac myocytes, indicating specific action on gap junctions.

Conclusions:

• The synthetic peptide AAP10 effectively increases cardiac gap junction conductance, thereby enhancing cellular coupling.
• This mechanism represents a novel approach for developing antiarrhythmic therapies with potentially fewer side effects.
• AAP10's specific action on gap junctions warrants further investigation as a new class of antiarrhythmic agents.